 Role antimicrobial agents treatment mixed aerobic anaerobic infections Mixed infections aerobic anaerobic bacteria frequency clinical practice Several concepts infections significant physician presence significance species Bacteroides fragilis group clinical sites infection facilitation fragilis virulence beta-lactamase aerobic bacteria role enterococci infections response need new forms therapy mixed aerobic anaerobic infections several new classes antimicrobial agents allow potential option monotherapy certain clinical settings addition clinical microbiologic efficacy safety cost-effectiveness factors regard agents